Topic:

Supply Chain

Latest Headlines

Latest Headlines

New plant pushes Ranbaxy Lipitor production to global lead

Getting FDA approval of a new plant in India meant Ranbaxy was able to push out enough generic Lipitor in March to take the top spot in production of the drug.

With new plant, Ranbaxy back in force in North America

After a four-year stint of being unable to ship drugs from its plants in India to the U.S. and Canada, Ranbaxy Laboratories is returning in a big way.

Here are some tips on cargo theft that might save you $75M

U.S. manufacturers have made a giant leap forward in protecting against cargo theft.

FDA creates new standard for cargo theft

Though pharmaceutical cargo theft has decreased dramatically in the U.S. the last couple of years, the FDA is displaying concern about the health risks stolen drugs can pose.

Sandoz Canada president explains shortages to House of Commons

Drug shortages brought on by difficulties at Sandoz's Boucherville, Quebec, plant have landed the president of the Novartis subsidiary in the hot seat before a committee of the Canadian House of Commons.

Novartis plant disruptions affect pet treatments

Manufacturing problems and disruptions at Novartis ($NVS) plants in Nebraska and Canada led to shortages that have left an ugly trail of unhappy healthcare providers and consumers.

Distribution, supply chain key to Eli Lilly's China expansion

Eli Lilly CEO John C. Lechleiter says the company has big plans for China, and a significant part of the success it expects there will come from expanding supply chain and distribution.

Cargo theft in Brazil violent and growing

As the 7th-largest world economy and one that has been growing at break-neck speed, Brazil is becoming a more important market for pharmaceuticals. But getting product delivered in the country can be...

UPDATED: FDA inspects three Merck KGaA plants along EU supply chain

The FDA found problems at three Merck KGaA API and drug manufacturing facilities along a single supply chain in Europe last summer from which ingredients were fed to a plant in Germany. It is unusual...

U.S. market size, shortages lead to more counterfeits

The size of the pharmaceutical market, the number of drugs in short supply, and the fact that many drugs sold in the U.S. are manufactured abroad all fit into the precise formulation for the...